Research progress of technology lipido-colloid for wound healing

doi:10.3877/cma.j.issn.1673-9450.2022.05.014

Abstract

Abstract:

Acute and chronic wounds seriously affect the quality of life of patients. How to promote acute wound healing and prevent its transformation into chronic wounds, and how to achieve complete healing of chronic wounds is a continuous concern for medical professionals. Based on the "wet wound healing theory" , technology lipid hydrocolloid (TLC) can effectively reduce patient pain, improve wound healing speed, and reduce the frequency of dressing changes. In this paper, we review the research on the effects and mechanisms of TLC at home and abroad, and discuss the progress of TLC in promoting wound healing from three aspects: introduction, in vitro effects and related mechanisms, and clinical effects, so as to provide new ideas for further application of TLC.

Key words: Technology lipido-colloid, Wound healing, Wet wound healing, Dressing, Pain

Chunli Wang, Zeyun Liu, Bing Yan, Emilio Galea. Research progress of technology lipido-colloid for wound healing[J]. Chinese Journal of Injury Repair and Wound Healing(Electronic Edition), 2022, 17(05): 454-456.

/ / Recommend

Add to citation manager EndNote|Ris|BibTeX

URL: https://zhssyxfzz.cma-cmc.com.cn/EN/10.3877/cma.j.issn.1673-9450.2022.05.014

https://zhssyxfzz.cma-cmc.com.cn/EN/Y2022/V17/I05/454

References 28

[1]	Ruggeri M, Bianchi E, Rossi S, et al. Nanotechnology-based medical devices for the treatment of chronic skin lesions: From research to the clinic[J]. Pharmaceutics, 2020, 12(9): 815.
[2]	Nicholas MN, Yeung J. Current status and future of skin substitutes for chronic wound healing[J]. J Cutan Med Surg, 2017, 21(1): 23-30
[3]	Ferriol A, Morán MDC. Enhanced performance of gelatin 5-fluorouracil-containing nanoparticles against squamous cell carcinoma in simulated chronic wounds conditions[J]. Mater Sci Eng C Mater Biol Appl, 2021, 124: 112073.
[4]	Khunkaew S, Fernandez R, Sim J. Health-related quality of life among adults living with diabetic foot ulcers: a meta-analysis[J]. Qual Life Res, 2019, 28(6): 1413-1427.
[5]	Macioch T, Sobol E, Krakowiecki A, et al. Health related quality of life in patients with diabetic foot ulceration - translation and Polish adaptation of Diabetic Foot Ulcer Scale short form[J]. Health Qual Life Outcomes, 2017, 15(1): 15.
[6]	Banharak S, Panpanit L, Subindee S, et al. Prevention and Care for Incontinence-Associated Dermatitis Among Older Adults: A Systematic Review[J]. J Multidiscip Healthc, 2021, 14: 2983-3004.
[7]	Juchaux F, Berger S, Bouschbacher M. Effects of Urgotul and Atrauman dressings on human fibroblast viability[N]. Harrogate: Wounds UK, 2009.
[8]	Winter GD. Formation of the scab and the rate of epithelialization of superficial wounds in the skin of the young domestic pig[J]. Nature，1962, 193: 293-294.
[9]	White R, Cowan T, Glover D. Supporting evidence-based practice: a clinical review of TLC technology[J]. Wound Care, 2011, 20: 1-36.
[10]	Benbow M, Iosson G. A clinical evaluation of Urgotul to treat acute and chronic wounds[J]. Br J Nurs, 2004, 13(2): 105-109.
[11]	Broussard KC, Powers JG. Wound dressings: selecting the most appropriate type[J]. Am J Clin Dermatol, 2013, 14(6): 449-459.
[12]	Nair H, Venkateshwaran N, Seetharaman SS, et al. Benefits of sucrose octasulfate (TLC-NOSF) dressings in the treatment of chronic wounds: a systematic review[J]. J Wound Care, 2021, 30(Sup4): S42-S52.
[13]	Desroche N, Dropet C, Janod P, et al. Antibacterial properties and reduction of MRSA biofilm with a dressing combining polyabsorbent fibres and a silver matrix[J]. J Wound Care, 2016, 25(10): 577-584.
[14]	Bainbridge P. Wound healing and the role of fibroblasts[J]. J Wound Care, 2013, 22(8): 407-408, 410-412.
[15]	Lipp C, Kirker K, Agostinho A, et al. Testing wound dressings using an in vitro wound model[J]. J Wound Care, 2010, 19(6): 220-226.
[16]	Viennet C, Bride J, Gabiot AC, et al. Comparison of different wound dressings on cultured human fibroblasts and collagen lattices[J]. J Wound Care, 2003, 12(10): 385-390.
[17]	Bernard FX, Barrault C, Juchaux F, et al. Stimulation of the proliferation of human dermal fibroblasts in vitro by a lipidocolloid dressing[J]. J Wound Care, 2005, 14(5): 215-220.
[18]	Bernard FX, Juchaux F, Laurensou C. Effects of a lipidocolloid dressing on the production of the extracellular matrix by human dermal fibroblasts in vitro[J]. Physical Chemistry, 2007, 12(58): 9-11.
[19]	Meaume S, Ourabah Z, Cartier H, et al. Evaluation of a lipidocolloid wound dressing in the local management of leg ulcers[J]. J Wound Care, 2005, 14(7): 329-334.
[20]	Benbow M, Iosson G. A clinical evaluation of Urgotul to treat acute and chronic wounds[J]. Br J Nurs, 2004, 13(2): 105-109.
[21]	Blanchet-Bardon C, Bohbot S. Using Urgotul dressing for the management of epidermolysis bullosa skin lesions[J]. Wound Care, 2005, 14(10): 490-491, 494-496.
[22]	Ma KK, Chan MF, Pang SM. The effectiveness of using a lipido-colloid dressing for patients with traumatic digital wounds[J]. Clin Nurs Res, 2006, 15(2): 119-134.
[23]	Baek W, Lee N, Han EJ, et al. A Prospective Randomized Study: The Usefulness and Efficacy of Negative Pressure Wound Therapy with Lipidocolloid Polyester Mesh Compared to Traditional Negative Pressure Wound Therapy for Treatment of Pressure Ulcers[J]. Pharmaceutics, 2020, 12(9): 813.
[24]	Meaume S, Téot L, Lazareth I, et al. The importance of pain reduction through dressing selection in routine wound management: the MAPP study[J].J Wound Care, 2004, 13(10): 409-413.
[25]	Denyer J, Pillay E, Clapham J. Best practice guidelines: skin and wound care in epidermolysis bullosa 2017[Z/OL]. Wounds International. [2017-05-03]. URL
[26]	Letouze A, Voinchet V, Hoecht B, et al. Using a new lipidocolloid dressing in paediatric wounds: results of French and German clinical studies[J]. J Wound Care. 2004, 13(6): 221-225.
[27]	Malmsjö M, Ingemansson R, Martin R, et al. Negative-pressure wound therapy using gauze or open-cell polyurethane foam: similar early effects on pressure transduction and tissue contraction in an experimental porcine wound model[J]. Wound Repair Regen, 2009, 17(2): 200-205.
[28]	Téot L, Lambert L, Ourabah Z, et al. Use of topical negative pressure with a lipidocolloid dressing: results of a clinical evaluation[J]. J Wound Care, 2006, 15(8): 355-358.

Please choose a citation manager

Content to export